Sinnecker, Tim
Ruberte, Esther
Schädelin, Sabine
Canova, Vera
Amann, Michael
Naegelin, Yvonne
Penner, Iris-Katharina
Müller, Jannis
Kuhle, Jens
Décard, Bernhard
Derfuss, Tobias
Kappos, Ludwig
Granziera, Cristina
Wuerfel, Jens
Magon, Stefano
Yaldizli, Özgür http://orcid.org/0000-0002-0800-4845
Article History
Received: 6 July 2019
Revised: 28 September 2019
Accepted: 30 September 2019
First Online: 14 October 2019
Compliance with ethical standards
:
: Tim Sinnecker is part-time employee of the Medical Image Analysis Center Basel. Esther Ruberte has nothing to disclose. Sabine Schädelin has nothing to disclose. Vera Canova has nothing to disclose. Michael Amann has nothing to disclose. Yvonne Naegelin has nothing to dislose. Iris-Katharina Penner has nothing to disclose. Jannis Müller has nothing to disclose. Jens Kuhle received speaker fees, research support, travel support, and/or served on advisory boards by ECTRIMS, Swiss MS Society, Swiss National Research Foundation [320030_160221], University of Basel, Bayer, Biogen, Genzyme, Merck, Novartis, Protagen AG, Roche, Teva. Bernhard Décard received travel support and/or fees for the institution [University Hospital Basel] from advisory boards or speaker fees from Allmirall, Biogen, Genzyme, Roche, Teva and Novartis, that were used exclusively for research support. Tobias Derfuss received speaker fees, research support, travel support, and/or served on Advisory Boards or Steering Committees of Novartis Pharma, Merck, Biogen, Teva, Bayer-Schering, GeNeuro, Mitsubishi Pharma, MedDay, Roche, and Genzyme; he received research support from Biogen, Novartis, Swiss National Research Foundation, University of Basel, and Swiss MS Society. Ludwig Kappos´s institution [University Hospital Basel] received and used exclusively for research support: steering committee, advisory board, and consultancy fees from Actelion, Addex, Bayer HealthCare, Biogen, Biotica, Celgene/Receptos, Genzyme, Lilly, Merck, Mitsubishi, Novartis, Ono Pharma, Pfizer, Sanofi, Santhera, Siemens, Teva, UCB, Xenoport; speaker fees from Bayer HealthCare, Biogen, Merck, Novartis, Sanofi, Teva; support of educational activities from Bayer HealthCare, Biogen, CSL Behring, Genzyme, Merck, Novartis, Sanofi, Teva; grants from Bayer HealthCare, Biogen, F. Hoffmann-La Roche Ltd, Merck, Novartis, the European Union, the Roche Research Foundations, the Swiss Multiple Sclerosis Society, the Swiss National Research Foundation. Cristina Granziera has nothing to disclose. Jens Wuerfel is CEO of the Medical Image Analysis Center Basel. Stefano Magon is employee from F. Hoffmann-La Roche AG. Özgür Yaldizli´s institution University Hospital Basel received grants from ECTRIMS/MAGNIMS, University of Basel, Pro Patient Stiftung University Hospital Basel, Free Academy Basel, Swiss Multiple Sclerosis Society and advisory board fees from Sanofi Genzyme, Biogen and Novartis Poland exclusively used for support of research and educational activities.